XSENSOR Earns the Frost & Sullivan 2022 Technology Innovation Leadership Award for Intelligent Dynamic Sensing Systems
Delivers innovative pressure measurement solutions to the world's most demanding customers. SAN ANTONIO, Sept. 29, 2022 /PRNewswire/ -- Based on its recent analysis of the sensor technology in the medical devices market, Frost & Sullivan recognizes XSENSOR Technology Corporation with the 2022 North America Technology Innovation Leadership Award. XSENSOR develops innovative sensing solutions for a spectrum of industries, including healthcare, engineering,...
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures optimized manufacturability of bispecific antibodies. DEVELOPICK™ provides early insight and selection guidance to save time and cost to maximize efficiency. INCHEON, South Korea, Sept. 29, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing...
NeuShen Therapeutics Closes Pre-A Financing with ~$20M
Closure of pre-A financing round led by LAMPAM Capital Dual internal discovery platforms of small molecule and AAV-based gene therapy targeting neurological and psychiatric disorders SHANGHAI, Sept. 29, 2022 /PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders with dual platforms of AAV-based gene therapy and small...
‘Generations Connect’ Project Brings Young People Together with the Elderly to Boost Emotional Resilience
Engaging tailored e-platform and healthcare students promote the wellbeing of the elderly HONG KONG, Sept. 29, 2022 /PRNewswire/ -- In recent years due to the COVID-19 pandemic, elderly people have had to stay mostly at home. Confined to small living spaces for prolonged periods, many senior citizens have been prone to emotional challenges, affecting their mental wellbeing and health....
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC
SUZHOU, China, Sept. 29, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the results from a phase Ib study of pruxelutamide (used to be called proxalutamide, GT0918) for the treatment of patients with androgen receptor positive (AR+) metastatic breast cancer (AR+ mBC) in China have...
Singapore SMEs Triumph Against New Challenges
25 Singaporean SMEs win the prestigious SME100 Awards SINGAPORE, Sept. 29, 2022 /PRNewswire/ -- 2022 sees the rising costs of raw materials and as the inflation rates soar and interest rates continue to rise, SMEs in Singapore managed to sustain their business and even displayed great resilience against the challenging environment. Congratulations to the...
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc
Simcere will receive a $15 million upfront payment, and up to $492 million in development and commercial milestone payments considering successful achievements in several indications, with an important part as sales milestones, as well as up to low double-digit tiered royalties based upon future global sales Under the agreement, Almirall will be granted an exclusive right to develop...
WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility in Worcester, Massachusetts
WORCESTER, Mass., Sept. 29, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO), held a topping-off ceremony, in partnership with the Worcester Business Development Corporation (WBDC), to mark the completion of the steel frame for WuXi Biologics' newest commercial biomanufacturing facility. Located in The Reactory, Worcester's biomanufacturing park developed by WBDC,...
Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution
Clinically-tested solution, based on a proprietary blend of six herbs used in Traditional Chinese Medicine, helps relieve symptoms of acne and other skin inflammation conditions. TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech (GMB), the developer of the synergistic herbal skincare combination Botaniplex™, and Kamedis, its parent company and the developer and marketer of end products...
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt)
YONGIN, South Korea and AUSTIN, Texas, Sept. 29, 2022 /PRNewswire/ -- GC Labs, a leading South Korea clinical laboratory, today announced that it has recently obtained certification of standardization programs from the U.S. Centers for Disease Control and Prevention (CDC) for vitamin D and hormones (testosterone). GC Labs becomes the first Korean...
